Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.
-
Upload
luke-underwood -
Category
Documents
-
view
215 -
download
0
Transcript of Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.
![Page 1: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/1.jpg)
Contraceptive Options for Women and Couples with HIV
Injectable Contraceptives
![Page 2: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/2.jpg)
Types of Injectable Contraceptives
Cyclofem,
Mesigyna
DMPA,
NET-EN
Type
1 month3 months,2 months
Duration of effect
progestin +estrogen
progestinHormones
CombinedProgestin-only
![Page 3: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/3.jpg)
Effectiveness
Source: CCP and WHO, 2007.
Oral contraceptives
Percentage of women pregnant in first year of use
Rate during typical use
Rate during perfect use
Female condom
Female sterilization
Implants
DMPA
Spermicides
Standard Days Method
Male condom
IUD (TCu-380A)
0 10 15 20 255 30
![Page 4: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/4.jpg)
DMPA – Mechanism of Action
Thickens cervical mucus to block sperm
Suppresseshormonesresponsible forovulation
![Page 5: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/5.jpg)
DMPA – Most Widely Used Injectable
• Best known as Depo-Provera
• Used by more than 14 million women worldwide
• Administered by deep intramuscular injection
• 150 mg every 3 months
• Injection site: upper arm or buttocks
![Page 6: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/6.jpg)
Characteristics of DMPA:
Advantages
• Safe
• Highly effective
• Easy to use
• Long acting
• Reversible
• Can be discontinuedwithout provider’s help
• Can be provided outside of clinics
• Requires no action at time of intercourse
• Use can be private
• Has no effect on lactation
• Has non-contraceptive health benefits
![Page 7: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/7.jpg)
Characteristics DMPA:
Non-contraceptive Health Benefits
DMPA use may reduce:
• Risk of endometrial cancer
• Risk of ectopic pregnancy
• Risk of symptomatic pelvic inflammatory disease
• Uterine fibroids
• Frequency and severity of sickle cell crises
• Symptoms of endometriosisSource: CCP and WHO, 2007.
![Page 8: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/8.jpg)
Characteristics DMPA:
Disadvantages
• Causes side effects, particularly menstrual changes
• Action cannot be stopped immediately
• Causes delay in return to fertility
• Provides no protection against STIs/HIV
![Page 9: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/9.jpg)
DMPA – Common Side Effects
• Menstrual changes– prolonged or heavy bleeding – irregular bleeding or spotting – amenorrhea (absence of menses)
• Weight gain
• Headaches, dizziness, changes in mood and sex drive
One third of users discontinue during One third of users discontinue during the first year because of side effects.the first year because of side effects.
Source: WHO, 1983.
![Page 10: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/10.jpg)
DMPA – Return to Fertility
• Does not permanently reduce fertility
• Length of time DMPA was used makes no difference
• Return to fertility depends on how fast woman fully metabolizes DMPA– on average, it takes 9 to 10 months for
women to become pregnant after their last injection
Source: Pardthaisong, 1984; Schwallie, 1974.
![Page 11: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/11.jpg)
Infant Exposure to DMPAthrough Breastfeeding
• DMPA has no effect on: – onset or duration of lactation – quantity or quality of breast milk – health and development of infant
• When to initiate: – after child is 6 weeks old (preferred)
Source: Koetsawang, 1987; WHO Task Force for Epidemiological Research on Reproductive Health, 1994; WHO, 2004; updated 2008.
![Page 12: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/12.jpg)
Effect of DMPA on Bone Density
• DMPA users have lower bone density than non-users
• Women initiating use as adults regain most lost bone
• Long-term effect in adolescents unknown – concern that osteoporosis may develop later – long-term studies are needed – generally acceptable to use
Source: Cromer, 1996; Cundy, 1994; WHO, 2004; updated 2008.
![Page 13: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/13.jpg)
Category 1 and 2 Examples (not inclusive): Who Can Use DMPA
≤18 years, adequately controlled hypertension, uncomplicated diabetes, gall-bladder disease
Category 2
heavy smokers, breastfeeding after six weeks postpartum, thyroid disorders, severe dysmenorrhea, uterine fibroids, STIs/PID, use of rifampicin or rifabutin, anticonvulsants, or any type of ARV drug
Category 1
ConditionsWHO
Category
Source: WHO, 2004; updated 2008.
![Page 14: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/14.jpg)
Category 3 and 4 Examples (not inclusive): Who Should Not Use DMPA
current breast cancerCategory 4
breastfeeding before 6 weeks postpartum, severe hypertension (≥160/≥100), vascular disease, acute DVT/PE, current or history of ischemic heart disease or stroke, complicated diabetes, severe liver disease and most liver tumors
Category 3
ConditionsWHO
Category
Source: WHO, 2004; updated 2008.
![Page 15: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/15.jpg)
DMPA Use by Women with HIV
• Women with HIV or AIDS can use without restrictions
• Nevirapine reduces blood progestin level by ~20%
• DMPA dose provides wide margin of effectiveness
• On-time injections emphasized
• Dual method use should be encouraged
WHO Eligibility CriteriaWHO Eligibility Criteria
Condition Category
HIV-infected 1
AIDS 1
ARV therapy 1
Source: WHO, 2004, updated 2008; Mildvan, 2002; Said, 1986.
![Page 16: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/16.jpg)
How to Take DMPA: When to Initiate
• Anytime during menstrual cycle if provider is reasonably sure woman is not pregnant – backup recommended if given after day 7
• Postpartum: – not breastfeeding: immediately – breastfeeding: delay 6 weeks
• Postabortion: immediately
Source: WHO, 2004; updated 2008.
![Page 17: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/17.jpg)
How to Take DMPA: Injection Schedule
• Injection every 3 months or 13 weeks
• Can be up to 2 weeks early or 4 weeks late
Source: WHO, 2004; updated 2008.
![Page 18: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/18.jpg)
Management of DMPA Side Effects:
Counseling about Bleeding
• Before first injection, counsel that bleeding changes are normal and expected
• Provide ongoing counseling and reassurance
• If client is concerned or bleeding is severe, treatment or discontinuation may be necessary
Counseling is the most important tool Counseling is the most important tool for managing bleeding irregularities.for managing bleeding irregularities.
![Page 19: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/19.jpg)
Management of DMPA Side Effects:
Treatment of Bleeding
• Treatment options
– ibuprofen (800 mg three times/day for 5 days)
– combined oral contraceptives (COCs) for 21 days
– with very heavy bleeding, rule out pregnancy or gynecological problems (uterine evacuation not indicated)
Iron supplements can help prevent anemia.Iron supplements can help prevent anemia.
Source: CCP and WHO, 2007; WHO, 2004; updated 2008.
![Page 20: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/20.jpg)
Management of DMPA Side Effects:
Amenorrhea
• Medical treatment not required
• If no reason to suspect pregnancy, counsel and reassure that amenorrhea is normal
• Pregnancy may need to be ruled out in some cases
![Page 21: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/21.jpg)
Sterile Injection Procedures
• Wash hands
• Clean injection site
• Use sterile needle and syringe
• Dispose of waste correctly
• Needles and syringes: – single-use must be disposed of safely– reusable must be sterilized
![Page 22: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/22.jpg)
Counseling about DMPA
Factors for clients to consider:
• Other available contraceptive options
• Characteristics (advantages and disadvantages)
• Side effects, including menstrual changes
• Timing of return to fertility
• Need for regular, timely injections
![Page 23: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/23.jpg)
Counseling about DMPA
continued ...
Messages after choosing DMPA:
• Do not massage injection site
• Expect bleeding 12–15 days after injection
• Return with problems or concerns
• No protection from STIs/HIV
![Page 24: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/24.jpg)
Counseling Reduces DMPA Discontinuation
• Menstrual changes most common reason for discontinuation
• Women receiving appropriate counseling more likely to continue using injectables
Source: Lei, 1996.
![Page 25: Contraceptive Options for Women and Couples with HIV Injectable Contraceptives.](https://reader035.fdocuments.in/reader035/viewer/2022062516/56649d745503460f94a54a5a/html5/thumbnails/25.jpg)
DMPA – Summary
• Safe, effective, easy to use
• Nonclinical provision possible
• Appropriate counseling essential